Loading...
01/10 19:54
Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call summary shows strong financial performance with a 50% increase in bookings and significant demand for AI products. The Q&A section indicates positive sentiment from analysts, with confidence in international growth and new product adoption. Although management was unclear on some details, the overall outlook is optimistic, especially with the AI Era Plan and counter-drone success. The combination of strong financial metrics, optimistic guidance, and product development suggests a positive stock price movement in the short term.
Revenue Second quarter revenue of $669 million increased 33% year-over-year. This marks the 14th consecutive quarter of over 25% revenue growth. The growth was driven by software and services, which grew 39% year-over-year to $292 million, and Connected Devices, which increased 29% year-over-year to $376 million.
Net Revenue Retention Net revenue retention increased to 124% and has been near or above 120% for 20 consecutive quarters. This demonstrates the results of ongoing investment in products and customers.
TASER Revenue TASER revenue grew 19% year-over-year, driven by the adoption of TASER 10.
Personal Sensors Revenue Personal sensors revenue grew 24% year-over-year, driven by Axon Body 4.
Platform Solutions Revenue Platform Solutions revenue grew 86% year-over-year, driven by counter-drone and virtual reality solutions.
Adjusted Gross Margin Adjusted gross margin was 63.3%, up 20 basis points year-over-year. This was driven by a product mix favoring software and services, partially offset by lower devices margin due to strong growth in newer hardware products and markets.
Adjusted EBITDA Margin Adjusted EBITDA margin was 25.7%, ahead of expectations due to higher revenue and operating leverage, as well as benefiting from the timing of tariffs.
Draft One: Fastest adopted software solution.
TASER 10: Fastest adopted TASER weapon.
Axon Body 4: Fastest adopted camera.
Dedrone, Fusus, and AI Era Plan: Deployed faster than prior technologies, laying groundwork for future innovations.
State and Local Team: Closed the largest deal in Axon history with a major city police department, including drones and AI products.
Corrections Team: Closed largest deal in team history, including TASER 10, body cameras, VR, evidence management, and Fusus.
International Expansion: Added a new TASER customer in Africa, becoming the largest in the region.
Enterprise Expansion: Signed a contract in the gaming space, including AI products, marking the first win in this vertical.
Revenue Growth: Q2 revenue of $669 million, a 33% year-over-year increase, marking 14 consecutive quarters of over 25% growth.
Software and Services: Revenue grew 39% year-over-year to $292 million, driven by new user adoption and new products.
Connected Devices: Revenue grew 29% year-over-year to $376 million, with TASER growing 19%, personal sensors 24%, and platform solutions 86%.
Net Revenue Retention: Increased to 124%, maintaining near or above 120% for 20 consecutive quarters.
Revenue Guidance: Raised 2025 revenue guidance to $2.65 billion to $2.73 billion, representing 29% annual growth at midpoint.
Adjusted EBITDA Guidance: Raised to $665 million to $685 million, maintaining a 25% margin target.
R&D Investments: Planned increase in hiring, particularly in R&D, to support product roadmap and new markets.
Tariff-related expenses: The company expects tariff-related expenses to impact financials more significantly in the second half of the year, which could affect profitability.
Lower devices margin: Strong growth in newer hardware products and markets has led to lower devices margin, which may continue to impact overall profitability.
Supply chain and investment balance: The company is balancing new investment areas and software business growth, which could pose challenges in maintaining profitability and operational efficiency.
Economic uncertainties: The company’s forward-looking statements acknowledge risks and uncertainties that could cause actual results to differ materially, indicating potential economic or market challenges.
Regulatory hurdles: The company’s products, such as drones and AI solutions, may face regulatory approval processes, which could delay adoption or increase costs.
Strategic execution risks: The company is heavily investing in R&D and new markets, which could pose risks if these investments do not yield expected returns or if execution falters.
Revenue Guidance: Axon has raised its 2025 revenue guidance to a range of $2.65 billion to $2.73 billion, representing approximately 29% annual growth at the midpoint.
Adjusted EBITDA Guidance: The company has increased its adjusted EBITDA guidance to a range of $665 million to $685 million, up from $650 million to $675 million, maintaining a 25% margin target for the year.
Hiring and R&D Investments: Axon plans to increase hiring, particularly in R&D, over the remainder of the year to support its product roadmap and new market opportunities, setting the stage for growth in 2026 and beyond.
Bookings Growth: The company expects year-over-year bookings growth in the high 30% range for the second half of 2025, aligning with the prior year's entire campaign.
The selected topic was not discussed during the call.
The earnings call summary and Q&A reveal a positive outlook with raised revenue and EBITDA guidance, strong product development, and international expansion. The Q&A section highlighted analysts' positive sentiment towards international deals and growth in various segments, including software and services. Despite some concerns about competition and tariffs, the overall sentiment remains positive, supported by strong bookings growth and strategic investments. The raised guidance and optimistic future outlook suggest a positive stock price reaction over the next two weeks.
The earnings call summary shows strong financial performance with a 50% increase in bookings and significant demand for AI products. The Q&A section indicates positive sentiment from analysts, with confidence in international growth and new product adoption. Although management was unclear on some details, the overall outlook is optimistic, especially with the AI Era Plan and counter-drone success. The combination of strong financial metrics, optimistic guidance, and product development suggests a positive stock price movement in the short term.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
